• American Diabetes Association. Test of Glycemia in Diabetes, in Clinical Practice Recommendations. Diabetes Care 2000 :.23 Suppl. 1.
  • Baynes, J. W., Bunn, H. F., and Goldstein, d. e., ET AL. National Diabetes Data Group. Report of the Expert Committee on Glucosylated Haemoglobin. Diabetes Care (1984) 7 : 602 – 606 
  • Bodor, G. S., Little, R. R., Garrett, N., Brown, W., Goldstein, D. E., and Nahm, M. H. Standardization of glycohaemoglobin determinations in the clinical laboratory : Three years of Experience. Clin. Chem. (1992) 38 : 2414 – 2418.
  • Craine, J. E. Latex agglutination immunoassays. 1987 American Laboratory 34. 
  • Curt L. Rohlfing, BES , Hsiao-Mei Wiedmeyer,MS, Randle R. Little, PHD, Jack D. England, Alethea Tennill, MS and David E. Goldstein, MD ‘Defining the Relationship Between Plasma Glucose and HbA1C, Analysis of glucose profiles and HbA1C in the Diabetes Control and Complications Trial’, Diabetes Care (2005) 22: 301-320 
  • DCCT research group. The effect of intensive treatment of diabetes on the development and progression of long – term complications in insulin – dependent diabetes mellitus. N. ENG. J. MED. (1994) 329 : 977 – 986, 467 – 592.
  • Diabetes Care (2002) 25: 275-278 
  • Eaton, S. E., Fielden, P., and Haisman, P. Glycated haemoglobin (HbA1C) measurements in subjects with haemoglobin variants, using the DCA 2000. Ann. Clin. Biochem (1997) 34 : 205 – 212.
  • Goldstein, D. E., Little, R. R., and Wiedmeyer, H. M. et al. Glycate haemoglobin : Methodologies and clinical application. Clin. Chem. (1986) 32 : B64 – B70.
  • Knowles, B. J., Haigh, W. B., Michaud, G. C., and Marchesi, V. T. A. monoclonal antibody – based immunoassay for haemoglobin A1c. Diabetes (1986) 35: Suppl. 94A.
  • Koening, R. J., Peterson, C. M., and Klio, C., et al. Hemoglobin A1c as an indicator of the degree of glucose intolerance in diabetes. Diabetes (1976) 25 : 230 – 232.
  • Larsen, M. L., Horder, M., and Mogensen, E. F. Effect of long – term monitoring of glycosylated haemoglobin levels in insulin – dependent diabetes mellitus. N. Eng J. Med. (1990) 323 : 1021 – 1025.
  • Mayer, T. K. and Freedman, Z. R. Protein glycosylation in diabetes mellitus: A review of laboratory measurements and oftheir clinical utility. Clin. Chem. Acta. (1983) 127 : 147-184
  • Nathan, D. M., Singer, D. E., Hurxthal, K., and Goodson, J.D. The clinical information value of the glycosylate haemoglobin assay. N. Eng. J. Med. (1984) 310 : 341 -346.
  • Nathan, D. M. Haemoglobin A1c – Infatuation or the real thing? N. Eng. J. Med. (1990) 323 : 1062 -1063.
  • Rose, A., Tongate, C., and Valdes, Jr., R. A haemoglobin A1C immunoassay method not affected by carbamylated hemoglobin. Ann. Clin. Lab. Science (1995) 25 : 13 – 19.
  • Jennie Brand – Miller, Ph. D., Kaye Foster – Powell, M. “The new glucose revolution”. Manage type 1 and 2 diabetes. Nutr. (2003)
  • Weykamp, C. W., Miedema, K., de Hann, T., and Doelman, C. J. A. Carbamylated Hemoglobin Interference in Glycohemoglobin Assays. Clin. Chem. (1993) 45 : 438 – 440.
  • Weykamp, C. W., Pender, T. J., Muskiet, F.J., and Van der Silk, W. Influence of haemoglobin variants and derivatives on glycohaemoglobin determinations, as investigated by 102 laboratories using 16 methods. Clin. Chem. (1993) 39 : 1717 – 1742

 

Καλωσήρθατε στον Γλυκό Πλανήτη!

Εγγραφείτε στο newsletter μας για να μαθαίνετε όλα τα νέα μας!
Email address
First Name
Last Name
Secure and Spam free...